Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium StudyRishi Lulla, Maryam Fouladi, Linda R. Bressler et al.|Neuro-Oncology|2016Cited by 140
MB-32 * FEASIBILITY OF VORINOSTAT COMBINED WITH ISOTRETINOIN AND CHEMOTHERAPY FOR YOUNG CHILDREN WITH NEWLY DIAGNOSED EMBRYONAL BRAIN TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDYSarah Leary, Maryam Fouladi, Lindsay Kilburn et al.|Neuro-Oncology|2015Cited by 5